Genetic heterogeneity in Alzheimer disease and implications for treatment strategies - Test2 - elhamkhani - TriplyDB

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

http://www.wikidata.org/entity/Q26995802

about

Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?The promise of multi-omics and clinical data integration to identify and target personalized healthcare approaches in autism spectrum disorders Therapeutic Applications of Rose Hips from Different Rosa Species.Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.Sleep, Cognition and Dementia.Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer's disease.New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics.Proteomics as an innovative tool to investigate frontotemporal disorders.Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease.Impairment of memory generalization in preclinical autosomal dominant Alzheimer's disease mutation carriers.The genes associated with early-onset Alzheimer's disease.Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.

P2860

Q26770781-E4C22AD4-DA24-4F49-9D49-D404D0985332 Q27005952-BB9AD781-9320-47A9-9EC4-BBC2CCD613DE Q33838470-7E845693-4A93-4A4D-89D3-2C530E9F3EF1 Q36615510-46A4B48A-F4D5-4ABA-9B8F-67B4117721CA Q37069525-1DCA70EC-D3BC-462D-ADAA-549D3BA48929 Q38610500-0C4E1184-304D-4CAC-B63E-1D3B7C79F9C6 Q38654257-BE330496-ED68-4AB2-9072-9A589969630A Q38796814-520E5698-EF13-46CE-8591-80A752D1F044 Q38802995-015FA623-8C4D-4EBA-B382-3F04B23E1CDB Q39339952-3D4FB23B-FF09-46B5-BB84-D41AE11585EB Q50421378-0AFBAB9C-5860-4996-B8DF-27F6B3FE1A5F Q52620416-BDDD77D3-547A-4DDF-90ED-16EA2DD7F37A Q55178076-94CF1E9C-71C2-4A18-8E86-3AE7DC3587E8

P2860

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

http://www.wikidata.org/entity/Q26995802

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

@ast

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

@en

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

@nl

type

label

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

@ast

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

@en

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

@nl

prefLabel

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

@ast

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

@en

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

@nl

P1433

Q26995802-2C8BD838-CA3B-463C-9484-1E4A86776CCA

P1476

Q26995802-F364CABE-30B3-4945-A0C2-3EE0BAAD6898

P2093

Q26995802-14755669-8730-488C-8513-8CCF75C56458

Q26995802-4AD0AE90-49FE-4CE9-B34F-609E9BFBE92D

Q26995802-66B98591-BC6B-409E-A433-4A20EA5815A7

Q26995802-8874D047-BC75-457D-BD39-EE9B3C6011AE

Q26995802-9B9F2410-3BAB-4634-8382-9DB407A2FC3F

Q26995802-FE7645B0-FBF2-4766-BDAF-B7C77E01EC11

P2860

Q26995802-0074BB46-DACA-4256-AE02-F71CEA2E8C36

Q26995802-0262A2D0-0336-4208-A29D-3C616F87924F

Q26995802-0626C973-E183-4D06-B8F0-C12CCC33D0D5

Q26995802-073B2EE0-227F-42D8-AD7A-9E2DF506A136

Q26995802-0F72CB80-25F6-4640-9034-1177F52110EE

Q26995802-144BD4F5-050B-4460-B09E-9AAAF62C4E05

Q26995802-16558048-1C4F-422D-9A51-4B0E686D26F2

Q26995802-173B73A5-FD61-4EA1-802F-FE41B415A25D

Q26995802-17E5BC8C-FBDF-4C50-8D14-EC7B3DD0D41B

Q26995802-17ECAC8C-6055-4041-A3E6-8752EC9923E3

P2888

Q26995802-472B11A5-542F-477E-B2DF-06A20A8979F9

P304

Q26995802-3E22779B-F132-43C9-AFCB-014CFC0FDDC4

P31

Q26995802-297F6399-93E7-4427-BEF3-ED7EF4D76FD1

Q26995802-962E2F10-E11F-456E-B0CE-528A85DF7E3E

P356

Q26995802-5DE9BBE0-9971-47A7-B2A4-293F8EB3E279

P407

Q26995802-67413800-C0ED-444D-9D82-9DCA7F24E843

P433

Q26995802-8069E93C-76C2-441E-9B9D-661A7BB4F36A

P478

Q26995802-7082D79E-5B03-49BA-AFF5-152BFB39A843

P50

Q26995802-6A7D92B7-1757-42BA-A6F8-89A0417FA80A

Q26995802-97AD77A8-A84C-4279-8706-77C99F3C9FE9

P577

Q26995802-114CB222-5389-4B9F-9FE9-BACB03F46EB1

Q26995802-F2D87771-7BDF-442E-920D-7365B7DC6B34

P5875

Q26995802-17127A56-8A61-4611-B2FE-3A4606F771A2

P6179

Q26995802-78CFC427-4D9D-4FE3-9250-A2A3D487A869

P698

Q26995802-E2482C21-61A6-427B-AE2B-62F343442614

P921

Q26995802-3B75ED21-07AD-4D87-9CB4-0FD8E956AB09

Q26995802-566FE2C6-5501-4D78-B62E-FCD8FF6397BF

Q26995802-696B79E4-9114-4A4B-BD1F-63803C9F99E3

P932

Q26995802-60A095FF-C3D7-4651-8EB4-C7C951C74419

P356

S11910-014-0499-8

P1433

Current Neurology and Neuroscience Reports

P1476

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

@en

P2093

Adrian Danek

http://www.w3.org/2001/XMLSchema#string

Bernardino Ghetti

http://www.w3.org/2001/XMLSchema#string

John C. Morris

http://www.w3.org/2001/XMLSchema#string

John M. Ringman

http://www.w3.org/2001/XMLSchema#string

Neill Graff-Radford

http://www.w3.org/2001/XMLSchema#string

Nigel J. Cairns

http://www.w3.org/2001/XMLSchema#string

P2860

Role of Genes and Environments for Explaining Alzheimer Disease

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

Alzheimer's disease and endocytic dysfunction: clues from the Down syndrome-related proteins, DSCR1 and ITSN1

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport

P2888

s11910-014-0499-8

P304

499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11910-014-0499-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Colin L. Masters

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265608377

http://www.w3.org/2001/XMLSchema#string

P6179

1005375681

http://www.w3.org/2001/XMLSchema#string

P698

25217249

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

genetic variation

membrane proteins

P932

4162987

http://www.w3.org/2001/XMLSchema#string